rs201855332

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_021098.3(CACNA1H):​c.4120G>A​(p.Val1374Met) variant causes a missense change. The variant allele was found at a frequency of 0.000338 in 1,605,478 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00035 ( 2 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

5
13
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 6.60

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.000354 (515/1453218) while in subpopulation AMR AF = 0.000559 (25/44716). AF 95% confidence interval is 0.000395. There are 2 homozygotes in GnomAdExome4. There are 227 alleles in the male GnomAdExome4 subpopulation. Median coverage is 39. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.4081G>A p.Val1361Met missense_variant Exon 21 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.4081G>A p.Val1361Met missense_variant Exon 21 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.4120G>A p.Val1374Met missense_variant Exon 21 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*90G>A non_coding_transcript_exon_variant Exon 21 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*2033G>A non_coding_transcript_exon_variant Exon 21 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*3567G>A non_coding_transcript_exon_variant Exon 20 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.4120G>A non_coding_transcript_exon_variant Exon 21 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*90G>A 3_prime_UTR_variant Exon 21 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000640028.1 linkn.*2033G>A 3_prime_UTR_variant Exon 21 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*3567G>A 3_prime_UTR_variant Exon 20 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152260
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000279
AC:
68
AN:
243392
AF XY:
0.000218
show subpopulations
Gnomad AFR exome
AF:
0.0000646
Gnomad AMR exome
AF:
0.000609
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000357
Gnomad OTH exome
AF:
0.00100
GnomAD4 exome
AF:
0.000354
AC:
515
AN:
1453218
Hom.:
2
Cov.:
39
AF XY:
0.000314
AC XY:
227
AN XY:
723292
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33464
American (AMR)
AF:
0.000559
AC:
25
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45502
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5530
European-Non Finnish (NFE)
AF:
0.000427
AC:
475
AN:
1111686
Other (OTH)
AF:
0.000216
AC:
13
AN:
60268
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152260
Hom.:
0
Cov.:
35
AF XY:
0.000188
AC XY:
14
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41464
American (AMR)
AF:
0.000131
AC:
2
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68046
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000749
Hom.:
0
Bravo
AF:
0.000253
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000214
AC:
26
EpiCase
AF:
0.000382
EpiControl
AF:
0.000533

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:2
Jul 19, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CACNA1H c.4120G>A (p.Val1374Met) results in a conservative amino acid change located in the Ion transport domain (IPR005821) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 243392 control chromosomes (gnomAD). To our knowledge, no occurrence of c.4120G>A in individuals affected with Idiopathic Generalized Epilepsy and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Jul 10, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Sep 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1374 of the CACNA1H protein (p.Val1374Met). This variant is present in population databases (rs201855332, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 446952). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CACNA1H protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.78
BayesDel_addAF
Uncertain
0.024
T
BayesDel_noAF
Pathogenic
0.16
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.82
D;.;.;.
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.94
D;D;D;.
M_CAP
Uncertain
0.28
D
MetaRNN
Uncertain
0.56
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.3
M;.;M;M
PhyloP100
6.6
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-2.4
N;.;N;N
REVEL
Pathogenic
0.82
Sift
Uncertain
0.0010
D;.;D;D
Sift4G
Uncertain
0.0030
D;.;D;D
Polyphen
1.0
D;.;D;D
Vest4
0.71
MVP
0.94
ClinPred
0.22
T
GERP RS
4.2
Varity_R
0.66
gMVP
0.82
Mutation Taster
=25/75
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201855332; hg19: chr16-1260868; API